10 Sep 2024 – PHAGElogist

ShigActive™, Phase 1 Randomized, Double-Blind Clinical Trial

Title: "Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial" https://www.mdpi.com/2079-6382/13/9/858 Bacterial diseases of the GI tract are a major global…